奥曲肽是普遍认可的治疗CID的常用药物。奥曲肽抑制胃酸分泌药，有利于提高培菲康的稳定性；抑制肠道平滑肌收缩，减少肠蠕动，有利于培菲康充分发挥作用。奥曲肽与培菲康共同应用时，两种药物相互促进和补充，做到标本兼治、作用持久，能够取得更加满意的治疗效果，是一种疗效满意、安全可靠的治疗方法，值得在临床中进一步推广。

    参考文献

    1 Saltz LB. Managing chemotherapy-induced diarrhea[J]. Clin Adv Hematol Oncol, 2006, 4(3): 203-204.

    2 Gibson RJ, Keefe DM. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies[J]. Support Care Cancer, 2006, 14(9): 890-900.

    3 Zhang Y, Dang C, Ma Q, et al. Predictors of systemic chemotherapy contraindication in pancreatic cancer patients with distant metastasis[J]. Hepatogastroenterology, 2007, 54(73): 254-259.

    4 National Cancer Institute, U.S. National Institutes of Health. Common terminology criteria for adverse events [online]. Ver. 3.0. December 12, 2003. National Cancer Institute criteria for severity of chemotherapy-induced diarrhea.

    5 周际昌. 实用肿瘤内科学(第二版)[M]. 北京：人民卫生出版社 ......